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Abstract 
Objective: To assess the utility of clinical features for diagnosis of streptococcal 
pharyngotonsillitis in pediatrics.
Methods: A total of 335 children aged 1-18 years old and presenting clinical manifestations 
of acute pharyngotonsillitis (APT) were subjected to clinical interviews, physical 
examinations, and throat swab specimen collection to perform cultures and latex 
particle agglutination tests (LPATs) for group A streptococcus (gAS) detection. Signs 
and symptoms of patients were compared to their throat cultures and LPATs results. A 
clinical score was designed based on the multivariate logistic regression analysis and 
also was compared to throat cultures and LPATs results. Positive throat cultures and/
or LPATs results were used as a reference standard to establish definitive streptococcal 
APT diagnosis. 
Results: 78 children (23.4%) showed positivity for gAS in at least one of the two diagnostic 
tests. coryza absence (odds ratio [oR]=1.80; p=0.040), conjunctivitis absence (oR=2.47; 
p=0.029), pharyngeal erythema (oR=3.99; p=0.006), pharyngeal exudate (oR=2.02; 
p=0.011), and tonsillar swelling (oR=2.60; p=0.007) were significantly associated with 
streptococcal pharyngotonsilitis. The highest clinical score, characterized by coryza 
absense, pharyngeal exudate, and pharyngeal erythema had a 45.6% sensitivity, a 74.5% 
especificity, and a likelihood ratio of 1.79 for streptococcal pharyngotonsilitis. 
Conclusions: clinical presentation should not be used to confirm streptococcal pharyn-
gotonsilitis, because its performance as a diagnostic test is low. Thus, it is necessary to 
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Introduction
Acute pharyngotonsillitis (APT) is a common health 
problem worldwide, especially in children, which is most 
often related to benign viral and self-limiting infections. 
However, a non-negligible number of these infections are of 
bacterial etiology, and in this case, the β-hemolytic group 
A streptococcus (gAS) is the main causative agent, which 
can lead to severe complications, with great individual, 
collective, social, and economic impact; the main 
complication is rheumatic fever (RF).1 
RF is a non-suppurative complication of APT caused by 
gAS and is characterized by the appearance of inflammatory 
changes in the joints, skin, heart, and central nervous 
system, disclosing different combinations and degrees 
of severity. of these, rheumatic carditis (Rc) is the most 
feared disease manifestation, as it is the only one that can 
result in sequelae, often severe, and lead to death.2 
considering its possible complications, it is essential 
to attain a correct diagnosis and adequate management 
of streptococcal APT, as its timely treatment (up to nine 
days of symptom onset) is effective in preventing both 
suppurative and non-suppurative complications.3 The 
diagnosis is challenging, as studies show a large overlap 
between the clinical presentation of viral and streptococcal 
APT, with no clinical feature that, individually, can confirm 
or rule out the diagnosis of streptococcal APT.4
However, there is no consensus of uniformity regarding the 
diagnosis and management of APT5 and some authors have 
developed scores to classify the risk of streptococcal APT, 
with varying results.6-9 Additionally, diagnostic laboratory 
tests, namely, culture or rapid antigen detection testing 
(RADT) are not always readily available or are not part of 
the reality of professionals that work directly with patients 
with APT.10 
According to estimates by the World Health organization, 
approximately 600 million new cases of symptomatic APT 
caused by gAS occur annually in children worldwide. of 
these, about 500,000 develop RF, and approximately 
develop 300,000 Rc. Most of these cases occur in less 
developed countries, with three times higher prevalence 
of RF in these countries, including Latin America, than in 
developed countries.1 
enhance laboratory test availability, especially of LPATs that allow an acurate and fast 
diagnosis of streptococcal pharyngotonsilitis. 
© 2014 Sociedade de Pediatria de São Paulo. Published by Elsevier Editora Ltda. All rights 
reserved.
Diagnóstico da faringoamigdalite estreptocócica em crianças e adolescentes: limi-
tações do quadro clínico 
Resumo 
Objetivo: Avaliar a utilidade do quadro clínico para o diagnóstico da faringoamigdalite 
estreptocócica na faixa pediátrica. 
Métodos: 335 indivíduos de 1 a 18 anos com quadro clínico de faringoamigdalite foram 
submetidos a anamnese, exame clínico, cultura e teste de aglutinação de partículas do 
látex (TAPL) para o estreptoco β-hemolítico do grupo A (EBHGA) em swab orofaríngeo. 
os sinais e sintomas foram comparados ao resultado da cultura e do TAPL e, em segui-
da, também o foi o agrupamento de sinais e sintomas definido por regressão logística 
multivariada, utilizado para gerar um escore clínico. Para o diagnóstico definitivo de 
faringoamigdalite estreptocócica, o padrão de referência foi a cultura e o TAPL, em 
paralelo.
Resultados: 78 indivíduos (23,4%) apresentaram resultados positivos para EBHgA em pelo 
menos um dos testes. Ausência de coriza (oR=1,80; p=0,04); ausência de conjuntivite 
(oR=2,44; p=0,029); hiperemia de orofaringe (oR=3,99; p=0,006); exsudato de orofa-
ringe (oR=2,02; p=0,011) e hipertrofia de amígdalas (oR=2,60; p=0,007) apresentaram 
associação significante com a faringoamigdalite estreptocócica. A pontuação máxima 
no escore clínico, no qual figuram três características (ausência de coriza, exsudato de 
orofaringe e hiperemia de orofaringe) correspondeu a uma sensibilidade de 45,6%, uma 
especificidade de 74,5% e uma likelihood ratio de 1,79 para a presença de faringoamig-
dalite estreptocócica.
Conclusão: o quadro clínico não deve ser usado isoladamente para confirmar o episódio 
de faringoamigdalite estreptocócica por apresentar um baixo desempenho diagnóstico. 
É necessário aumentar a disponibilidade de testes laboratoriais, em especial o TALP, que 
permite o diagnóstico rápido e acurado deste episódio. 
© 2014 Sociedade de Pediatria de São Paulo. Publicado por Elsevier Editora Ltda. Todos os 
direitos reservados.
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In Brazil, the Brazilian Societies of cardiology, Pediatrics, 
and Rheumatology estimates that approximately 10 million 
cases of streptococcal APT occur every year, which would 
account for 30,000 new cases of RF, of which approximately 
15,000 would develop cardiac involvement. In 2007 alone, 
the Brazilian Unified Health System (Sistema Único de 
Saúde SUS]) spent approximately R$ 170 million in hospital 
admissions due to RF or Rc and, of cardiac surgeries 
performed that year, 31% occurred in patients with RF 
sequelae.2 
The aim of this study is to evaluate the usefulness of the 
clinical picture for the diagnosis of streptococcal APT and 
to define a group of signs and symptoms that can maximize 
their diagnostic power. 
Method
This study was conducted in patients aged 18 or younger that 
presented with complaints of sore throat and/or pharyngeal 
and/or tonsillar erythema at admission in an emergency 
department and a pediatric outpatient clinic in the city of Belo 
Horizonte, state of Minas gerais, Brazil, and was approved 
by the Ethics committee of Universidade Federal de São 
João Del Rey (UFSJ) under number 05705112.6.0000.5545. 
Patients who had received benzathine penicillin in the past 
30 days or any other antimicrobial agent in the past 15 days 
were excluded from the study.
Signs and symptoms associated with upper respiratory tract 
and APT were assessed and recorded on a standardized form. 
Additionally, signs and symptoms that were often not assessed 
in similar studies were investigated, such as the following: 
gingivitis, tearing, tonsillar pillar erythema, sneezing, and 
prostration during and between fever peaks (>38.5°c):
After obtaining consent from the parents or guardians, 
the physical examination was performed, and the latex 
particle agglutination test (LPAT) and oropharyngeal 
cultures obtained independently and in a blinded fashion 
were performed. Two swabs were obtained from each 
patient, one for the LPAT (PathoDx®, DPc – Los Angeles, 
United States) and the other for the conventional culture 
on sheep blood agar plate at 5%. 
Differently from almost all published studies on this 
subject, the protocol included not only the throat culture 
as the gold standard, but rather a better and more robust 
reference standard, that is, the combination in parallel 
of oropharyngeal culture results and LPAT. The definitive 
diagnosis of streptococcal APT was given when the culture 
or LPAT were positive; conversely, a negative result for both 
culture and LPAT ruled out the diagnosis of streptococcal 
APT, thereby increasing sensitivity.
Sensitivity and specificity were calculated for each 
sign and symptom, with their respective 95% confidence 
intervals (95% cI). The positive likelihood ratio (LR+), odds 
ratio (oR), and p-value for each sign and symptom were 
also calculated. The chi-squared test was used to determine 
statistical significance. 
Signs and symptoms that showed p-values  <0.20 were 
submitted to multivariate analysis using a logistic regression 
model to develop a clinical prediction score. The sensitivity, 
specificity, and LR+ were then calculated for each score.
Results
A total of 335 patients were considered eligible, of whom 
56 (16.72%) were positive for gAS culture, 71 (21.2%) for 
LPAT, and 78 (23.4%) for LPAT and/or culture. The agreement 
between the tests was 91.3%, with a kappa of 0.72. The 
sensitivity, specificity, LR+ and the oR and p-values  were 
calculated for each clinical feature observed in the interview 
and clinical examination, and are shown in Table 1. 
It can be observed that the clinical characteristic with 
the highest sensitivity for the diagnosis of APT by gAS was 
tonsillar erythema (96.2%), followed by oropharyngeal 
erythema (94.7%), fever reported by the parent or 
guardian (93.6%), and absence of conjunctivitis (91.0%). 
However, all these characteristics had low specificity 
(10.8%, 18.2%, 14.6%, and 19.6%, respectively). The 
clinical characteristic with the highest specificity 
was the presence of exanthema (94.4%), followed by 
gingivitis (92.3%), palatal petechiae (83.3%), and axillary 
temperature measured at the consultation >38.5ºc 
(82.3%), but all with low sensitivity (8.9%, 3.9%, 21.8%, 
and 16.4%, respectively). 
The characteristics statistically associated with APT 
by gAS (p<0.05) were absence of rhinorrhea (oR=1.80, 
p=0.040); absence of conjunctivitis (oR=2.47, p=0.029); 
oropharyngeal erythema (oR=3.99, p=0.006); oropharyngeal 
exudate (oR=2.02, p=0.011); and tonsillar hypertrophy 
(oR=2.60, p=0.007).
The characteristics with the highest likelihood ratios 
were exanthema (1.50); oropharyngeal exudate (1.40), and 
palatal petechiae (1.31). However, both palatal petechiae 
and exanthema had wide confidence intervals.
The characteristics included in the logistic regression 
analysis were: reported fever, absence of rhinorrhea, 
absence of conjunctivitis, loss of appetite, oropharyngeal 
erythema, oropharyngeal exudate, tonsillar erythema, and 
hypertrophy. The analysis was performed using the stepwise 
model. The following characteristics were retained in the 
model, according to the program: absence of rhinorrhea; 
oropharyngeal erythema, and exudate (Table 2). The results 
of the combination of these characteristics generated a 
score in which each corresponds to a point, as shown in 
Table 3.
As expected, it can be observed that the higher the 
score, the greater the specificity and the lower the 
sensitivity of the clinical picture. Thus, a score of 3 points, 
or the presence of the three characteristics (absence of 
rhinorrhea, oropharyngeal exudate, and oropharyngeal 
erythema) corresponds to a sensitivity of 45.6%, a specificity 
of 74.5%, and an LR+ of 1.79. This LR+ is higher than in any 
of the clinical characteristics alone, corresponding to the 
best performance of the clinical picture in these results.
Discussion
In this study, the prevalence of gAS in children and 
adolescents with APT was 23%, lower than that estimated 
by the work of Shaikh, Leonard, and Martin.11 In their 
meta-analysis, the prevalence of the 14 studies analyzed 
together was 37%. However, the authors emphasize that 
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there was great heterogeneity among these studies and 
that prevalence ranged from 17% to 58% in them.
Several studies have been published aiming to elucidate 
the clinical picture accuracy for the etiological diagnosis 
of APT in children, with variable results.7,8,12-15 Rimoin et 
al16 demonstrated the existence of significant variation in 
the clinical presentation of APT in four different countries, 
suggesting it is inadequate to extrapolate conclusions 
about the clinical picture accuracy from one region to 
another. Therefore, the importance of the present study 
is emphasized, conducted in a country where RF and its 
complications are a major public health problem. 
clinical characteristics statistically associated with 
the presence of gAS vary among studies:7,8,12-15 palatal 
petechiae; anterior cervical adenopathy; oropharyngeal 
Table 1 clinical picture accuracy for the diagnosis of streptococcal APT.
Clinical characteristic  Sensitivity (%) Specificity (%) Likelihood ratio + Odds ratio p-value
Sore throat 79.20 (68.88-86.79) 19.90 (15.49-25.24) 0.99 (0.97-1.00) 0.95 (0.51-1.78) 0.869
Axillary temperature 16.42 (9.42-27.06) 82.3 (76.55-86.87) 0.93 (0.35-2.42) 0.91 (0.44-1.91) 0.809
Reported fever 93.59 (85.86-97.23) 14.57 (10.76-19.43) 1.09 (1.08-1.11) 2.49 (0.94-6.57) 0.058
Headache 61.54 (50.44-71.55) 35.57 (29.93-41.65) 0.95 (0.92-0.99) 0.88 (0.52-1.49) 0.643
Absence of coughing 46.15 (35.53-57.14) 59.77 (53.66-65.59) 1.15 (1.06-1.25) 1.27 (0.76-2.12) 0.353
Absence of rhinorrhea 74.36 (63.69-82.74) 38.34 (32.57-44.46) 1.21 (1.18-1.24) 1.80 (1.02-3.18) 0.040
Absence of conjunctivitis 91.03 (82.62-95.58) 19.61 (15.20-24.92) 1.13 (1.12-1.15) 2.47 (1.07-5.71) 0.029
Prostration 71.79 (60.97-80.57) 29.02 (23.79-34.87) 1.01 (0.97-1.04) 1.04 (0.59-1.83) 0.889
Loss of appetite 76.92 (66.44-84.87) 31.87 (26.42-37.87) 1.12 (1.10-1.15) 1.56 (0.86-2.81) 0.138
Vomiting 39.74 (29.61-50.84) 62.89 (56.82-68.58) 1.07 (0.95-1.20) 1.12 (0.66-1.88) 0.674
Abdominal pain 37.18 (27.29-48.27) 62.20 (56.10-67.94) 0.98 (0.86-1.25) 0.97 (0.86-1.13) 0.922
Absence of tearing 82.05 (72.10-89.00) 22.13 (17.46-27.65) 1.05 (1.03-1.07) 1.29 (0.68-2.49) 0.429 
Exanthema 8.97 (4.42-17.38) 94.40 (90.82-96.64) 1.50 (0.07-29.29) 1.66 (0.65-4.28) 0.288
Absence of sneezing 66.67 (55.64-76.13) 36.86 (31.18-42.94) 1.05 (1.02-1.09) 1.17 (0.68-1.99) 0.570
gingivitis 3.89 (1.33-10.84) 92.28 (91.92-97.28) 0.82 (0.00-97.00) 0.82 (0.22-2.98) 0.760
oropharyngeal erythema 94.74 (87.23-97.93) 18.15 (13.85-23.42) 1.16 (1.14-1.17) 3.99 (1.39-11.49) 0.006 
oropharyngeal exudate 60.00 (48.29-70.67) 57.40 (50.84-63.71) 1.40 (1.34-1.48) 2.02 (1.17-3.49) 0.011 
Palatal erythema 62.82 (51.73-72.71) 43.03 (37.05-49.21) 1.10 (1.06-1.14) 1.28 (0.76-2.15) 0.360
Palatal petechiae 21.79 (14.08-32.16) 83.33 (78.24-87.43) 1.31 (0.82-2.07) 1.39 (0.74-2.62) 0.302
Tonsillar Erythema 96.15 (89.29-98.68) 10.76 (7.49-15.20) 1.08 (1.07-1.09) 3.01 (0.98-10.22) 0.064 
Tonsillar hypertrophy 87.18 (77.98-92.88) 27.67 (22.52-33.48) 1.20 (1.19-1.22) 2.60 (1.27-5.34) 0.007 
Tonsillar pillar erythema 87.18 (77.98-92.88) 13.04 (9.44-17.75) 1.00 (0.99-1.02) 1.02 (0.48-2.18) 0.959 
overall compromised state 80.30 (69.16-88.11) 18.00 (13.29-23.91) 0.97 (0.96-1.00) 0.89 (0.44-1.81) 0.758 
at fever peaks
overall compromised 34.67 (24.88-45.95)  67.86 (61.48-73.63) 1.08 (0.91-1.28) 1.12 (0.65-1.95) 0.687 
state between fever peaks
cervical lymphadenopathy 35.14 (25.24-46.50) 63.52 (57.32-69.31) 0.96 (0.82-1.13) 0.94 (0.55-1.63) 0.834
95% confidence interval
exudate; sore throat; tonsillar hypertrophy; scarlet fever-
like rash, fever >38°c; muscle pain; bad breath; oral 
ulcers; gastrointestinal symptoms; contact with patients 
with APT by gAS; age 5 to 12 years; and oropharyngeal 
erythema appear alone or in different combinations in 
the several studies. Rhinorrhea, cough, and conjunctivitis 
usually appear as symptoms associated with viral infection 
(p<0.05). However, none of these characteristics is unique 
to streptococcal or viral APT. Moreover, none of them 
show, concomitantly, high sensitivity and specificity for the 
diagnosis of streptococcal APT. 
The results of the present study support this information, 
showing characteristics with high sensitivity, but low 
specificity (tonsillar erythema, oropharyngeal erythema, 
reported fever, and absence of conjunctivitis) and conversely, 
Table 2 Results of the multivariate logistic regression analysis with stepwise model.
clinical characteristic  odds ratio Adjusted odds ratio  p-valuer
Absence of rhinorrhea 1.80 (1.02-3.18) 1.97 (1.04-3.74) 0.037
oropharyngeal erythema 3.99 (1.39-11.49) 4.35 (1.28-14.74) 0.018
oropharyngeal exudate 2.02 (1.17-3.49) 1.63 (0.92-2.88) 0.095
95% confidence interval
Diagnosis of streptococcal tonsillopharyngitis 289
characteristics with high specificity but low sensitivity 
(presence of exanthema, gingivitis, palatal petechiae, and 
axillary temperature >38.5°c). The characteristic with the 
greatest balance between sensitivity and specificity was 
oropharyngeal exudate, with 60% and 57.4%, respectively.
Furthermore, the characteristics statistically associated 
with the presence of gAS in this study, namely, the absence 
of rhinorrhea, absence of conjunctivitis, oropharyngeal 
erythema, oropharyngeal exudate, and tonsillar 
hypertrophy, were different from those obtained in other 
studies performed in Brazil.8,15,16 This further supports the 
finding of the variability of manifestations in streptococcal 
APT, even within the same country. 
none of the characteristics analyzed in this study 
showed a high likelihood ratio. The characteristics with 
higher likelihood ratios were: exanthema (LR=1.50, 95% 
cI: 0.07-29.29); oropharyngeal exudate (LR=1.40, 95% cI: 
1.34-1.48); and palatal petechiae (LR=1.31, 95% cI: 0.82-
2.07). It was observed, however, that both exanthema and 
palatal petechiae showed wide confidence intervals that 
include 1, which makes the results inaccurate and of little 
significance. nevertheless, any of these values cause very 
little change to  the pre-test probability of streptococcal 
APT. considering a mean prevalence of 30% of gAS as the 
cause of APT,17 a positive likelihood ratio of 1.4, as observed 
for oropharyngeal exudate, would increase the post-test 
likelihood to only about 35%.
In an attempt to increase the diagnostic usefulness of 
the clinical picture, some authors have proposed the use of 
clinical prediction scores. Thus, McIsaac et al6 obtained a 
score with a sensitivity and specificity of 66.1% and 85.4%, 
respectively. However, the sample used by these authors 
consists mostly of adult patients, although their score is 
corrected for age.
Smeesters et al8 and Joachim, campos and Smeesters9 
developed their scores aiming to diagnose cases of non-
streptococcal APT. They obtained scores with sensitivity 
and specificity for this purpose of 41% and 84%, and 35% 
and 88%, respectively. nonetheless, the aim of these scores 
is to provide an alternative to microbiological tests for 
the correct management of the APTs, that is, to provide 
adequate antibiotic therapy when required and avoid its 
use when unnecessary, especially given the current concern 
with bacterial resistance development.18
In the present study, a sensitivity of 45.6% was obtained 
(95% cI: 34.3 to 57.3%) and a specificity of 74.5% (95% cI: 
68.3 to 79.9%) when the three associated symptoms of 
APT by gAS were combined after the multivariate logistic 
regression. This also corresponds to a likelihood ratio of 
Table 3 Score and performance of clinical score, consisting of absence of rhinorrhea, oropharyngeal erythema, and exudate 
for the clinical diagnosis of streptococcal pharyngotonsillitis.
Score (points) Sensitivity (%) Specificity (%) Likelihood ratio
0 (12) 100 0 0
1 (71) 100 (94.65-100.00) 5.56 (3.21-9.46) 1.06 (1.05-1.07)
2 (115) 85.29 (75.00-91.81) 33.80 (27.82-40.34) 1.29 (1.26-1.31)
3 (86) 45.59 (34.3-57.34) 74.54 (68.33-79.88) 1.79 (1.60-2.00)
95% confidence interval
1.79 (95% cI: 1.60-2.00). As the score has low sensitivity, it 
does not allow ruling out the diagnosis of streptococcal APT 
only by this criterion. Despite the moderate specificity, the 
score of 3 points has a likelihood ratio that is considered 
low. once again, with the example of a streptococcal 
APT prevalence of 30% (pre-test likelihood), a post-test 
likelihood of 40% would be obtained, which is not enough 
to confirm the diagnosis.
considering the important impact of APT, especially 
RF and Rc, particularly in less developed countries, it is 
necessary to consider and define what would be the best 
strategy for the diagnosis and management of APTs, taking 
into account individual and collective risks, availability of 
laboratory tests for the diagnosis, the limitations of these 
tests, and the costs of each strategy, without losing sight 
of the possible complications of each one.
Thus, some authors have made efforts to define 
which strategy would be the most appropriate for APT 
management.19-22 giraldez-garcia et al,19 for instance, 
analyzed the cost, the effectiveness, and the cost/
effectiveness ratio of six different strategies for APT 
management in Spain and concluded that the best strategy 
for that country, in terms of cost and cost/effectiveness, 
would be the use of a clinical score, followed by rapid test 
for patients with a high score, for diagnostic confirmation. 
By applying this strategy to the present study population, 
30% of the patients would be tested, an inadequate antibiotic 
would not be used in any of the cases negative for gAS, but 
57% of positive cases would not be properly treated, an 
unacceptable percentage. nevertheless, this extrapolation 
is only a theoretical exercise, as the information used by 
these researchers may not apply to Brazil, in the context 
of the abovementioned considerations on the variability 
of APT between different regions. Moreover, the clinical 
criteria used by the Spanish authors differ from those found 
in this study.
The literature review showed only one study that, as the 
present, used the combination of culture and rapid antigen 
detection test as the reference standard.9 However, in that 
study, children undergoing culture were not submitted to 
RADT and vice versa, as the study was performed in two 
steps, and one of the tests was used in each step. In the 
present, all patients were submitted to the two tests. 
considering that, in practice, the positive result of both 
the culture and the RADT should be seen as positive, it is 
considered that the methodology applied in this study is 
closer to the reality. Furthermore, the use of two highly 
specific tests reduces the possibility of false negative 
results, by increasing the standard sensitivity. 
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This study has some limitations. First, due to the 
incapacity of reference standards, LPAT, culture, or a 
combination of both, to differentiate patients with gAS, 
one may have underestimated the actual accuracy of the 
clinical picture for the diagnosis for APT. Some studies 
estimate a prevalence of approximately 10% of gAS in healthy 
carriers;11,23 however, there are no accurate and practical 
methods to differentiate symptomatic patients (infected 
by another microorganism rather than gAS) from those 
infected by it. Moreover, as the study had a cross-sectional 
design, the impact that subsequent assessments might have 
on clinical picture accuracy could not be assessed. That 
would be important, as a frequent conduct in APT cases is 
to wait for the evolution within 24 to 48 hours to reassess 
children and define the therapeutic strategy.
no studies in the literature that used such approach were 
found. Thus, it would be important, given the information 
already available and the contribution of this work, to 
perform longitudinal studies to sequentially evaluate 
patients and assess whether such a measure would increase 
the diagnostic accuracy of the clinical picture. Moreover, 
it would be worthwhile to perform a cost/effectiveness 
analysis that would more adequately apply to the Brazilian 
reality, and that of other developing and underdeveloped 
countries. 
The present results show that the clinical picture should 
not be used alone to confirm the episode of streptococcal 
APT. Even when some clinical features are combined, the 
resulting positive likelihood ratio does not allow increasing 
the post-test likelihood to a sufficiently high value to 
confirm the diagnosis of streptococcal APT. It is necessary 
to increase the availability of confirmatory laboratory 
tests, especially RADT, which allows a rapid and accurate 
diagnosis of the streptococcal APT episode.
In view of the Brazilian reality, where there is scarce 
availability and request for confirmatory laboratory tests in 
a continuous feedback, it would be important that medical 
societies, such as the Brazilian Society of Pediatrics, the 
Brazilian Society of Infectious Diseases, and the Brazilian 
Society of cardiology, as well as the Ministry of Health, 
issue a recommendation for the correct diagnosis and 
management of APT. Thus, there would be an incentive, to 
medical professionals, as well as laboratories, to request 
and provide the necessary tests for the diagnosis and 
management of APT. 
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